Predictive Models in Differentiating Vertebral Lesions Using Multiparametric MRI

References

1. 1.↵
   2. Cuénod CA,
   3. Laredo JD,
   4. Chevret S, et al

   . Acute vertebral collapse due to osteoporosis or malignancy: appearance on unenhanced and gadolinium-enhanced MR images. Radiology 1996;199:541–49 doi:10.1148/radiology.199.2.8668809 pmid:8668809

   CrossRefPubMed
2. 2.↵
   2. An HS,
   3. Andreshak TG,
   4. Nguyen C, et al

   . Can we distinguish between benign versus malignant compression fractures of the spine by magnetic resonance imaging? Spine (Phila Pa 1976) 1995;20:1776–82 doi:10.1097/00007632-199508150-00005 pmid:7502133

   CrossRefPubMed
3. 3.↵
   2. Yuh WT,
   3. Zachar CK,
   4. Barloon TJ, et al

   . Vertebral compression fractures: distinction between benign and malignant causes with MR imaging. Radiology 1989;172:215–18 doi:10.1148/radiology.172.1.2740506 pmid:2740506

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Baur A,
   3. Stäbler A,
   4. Arbogast S, et al

   . Acute osteoporotic and neoplastic vertebral compression fractures: fluid sign at MR imaging. Radiology 2002;225:730–35 doi:10.1148/radiol.2253011413 pmid:12461253

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Dwivedi DK,
   3. Kumar R,
   4. Bora GS, et al

   . Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI). NMR Biomed 2016;29:232–38 doi:10.1002/nbm.3452 pmid:26730884

   CrossRefPubMed
6. 6.↵
   2. Kimura M,
   3. da Cruz LC Jr.

   . Multiparametric MR imaging in the assessment of brain tumors. Magn Reson Imaging Clin N Am 2016;24:87–122 doi:10.1016/j.mric.2015.09.001 pmid:26613877

   CrossRefPubMed
7. 7.↵
   2. Rahbar H,
   3. Partridge SC

   . Multiparametric MR imaging of breast cancer. Magn Reson Imaging Clin N Am 2016;24:223–38 doi:10.1016/j.mric.2015.08.012 pmid:26613883

   CrossRefPubMed
8. 8.↵
   2. Ro SR,
   3. Asbach P,
   4. Siebert E, et al

   . Characterization of orbital masses by multiparametric MRI. Eur J Radiol 2016;85:324–36 doi:10.1016/j.ejrad.2015.11.041 pmid:26781137

   CrossRefPubMed
9. 9.↵
   2. Erly WK,
   3. Oh ES,
   4. Outwater EK

   . The utility of in-phase/opposed-phase imaging in differentiating malignancy from acute benign compression fractures of the spine. AJNR Am J Neuroradiol 2006;27:1183–88 pmid:16775260

   Abstract/FREE Full Text
10. 10.↵
    2. Castillo M,
    3. Arbelaez A,
    4. Smith JK, et al

    . Diffusion-weighted MR imaging offers no advantage over routine noncontrast MR imaging in the detection of vertebral metastases. AJNR Am J Neuroradiol 2000;21:948–53 pmid:10815675

    Abstract/FREE Full Text
11. 11.↵
    2. Maeda M,
    3. Sakuma H,
    4. Maier SE, et al

    . Quantitative assessment of diffusion abnormalities in benign and malignant vertebral compression fractures by line scan diffusion-weighted imaging. AJR Am J Roentgenol 2003;181:1203–09 doi:10.2214/ajr.181.5.1811203 pmid:14573404

    CrossRefPubMed
12. 12.↵
    2. Zhou XJ,
    3. Leeds NE,
    4. McKinnon GC, et al

    . Characterization of benign and metastatic vertebral compression fractures with quantitative diffusion MR imaging. AJNR Am J Neuroradiol 2002;23:165–70 pmid:11827890

    Abstract/FREE Full Text
13. 13.↵
    2. Israel GM,
    3. Korobkin M,
    4. Wang C, et al

    . Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol 2004;183:215–19 doi:10.2214/ajr.183.1.1830215 pmid:15208141

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Namimoto T,
    3. Yamashita Y,
    4. Mitsuzaki K, et al

    . Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. Radiology 2001;218:642–46 doi:10.1148/radiology.218.3.r01mr15642 pmid:11230633

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Haider MA,
    3. Ghai S,
    4. Jhaveri K, et al

    . Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 2004;231:711–16 doi:10.1148/radiol.2313030676 pmid:15118113

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Earls JP,
    3. Krinsky GA

    . Abdominal and pelvic applications of opposed-phase MR imaging. AJR Am J Roentgenol 1997;169:1071–77 doi:10.2214/ajr.169.4.9308467 pmid:9308467

    CrossRefPubMed
17. 17.↵
    2. Rofsky NM,
    3. Weinreb JC,
    4. Ambrosino MM, et al

    . Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging. J Comput Assist Tomogr 1996;20:230–35 doi:10.1097/00004728-199603000-00012 pmid:8606229

    CrossRefPubMed
18. 18.↵
    2. Baker LL,
    3. Goodman SB,
    4. Perkash I, et al

    . Benign versus pathologic compression fractures of vertebral bodies: assessment with conventional spin-echo, chemical-shift, and STIR MR imaging. Radiology 1990;174:495–502 doi:10.1148/radiology.174.2.2296658 pmid:2296658

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Rosen BR,
    3. Fleming DM,
    4. Kushner DC, et al

    . Hematologic bone marrow disorders: quantitative chemical shift MR imaging. Radiology 1988;169:799–804 doi:10.1148/radiology.169.3.3187003 pmid:3187003

    CrossRefPubMed
20. 20.↵
    2. Disler DG,
    3. McCauley TR,
    4. Ratner LM, et al

    . In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water. AJR Am J Roentgenol 1997;169:1439–47 doi:10.2214/ajr.169.5.9353477 pmid:9353477

    CrossRefPubMed
21. 21.↵
    2. Eito K,
    3. Waka S,
    4. Naoko N, et al

    . Vertebral neoplastic compression fractures: assessment by dual-phase chemical shift imaging. J Magn Reson Imaging 2004;20:1020–24 doi:10.1002/jmri.20213 pmid:15558548

    CrossRefPubMed
22. 22.↵
    2. Garg RK,
    3. Somvanshi DS

    . Spinal tuberculosis: a review. J Spinal Cord Med 2011;34:440–54 doi:10.1179/2045772311Y.0000000023 pmid:22118251

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Daffner RH,
    3. Lupetin AR,
    4. Dash N, et al

    . MRI in the detection of malignant infiltration of bone marrow. AJR Am J Roentgenol 1986;146:353–58 doi:10.2214/ajr.146.2.353 pmid:3484586

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Baur A,
    3. Stäbler A,
    4. Bruning R, et al

    . Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures. Radiology 1998;207:349–56 doi:10.1148/radiology.207.2.9577479 pmid:9577479

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Spuentrup E,
    3. Buecker A,
    4. Adam G, et al

    . Diffusion-weighted MR imaging for differentiation of benign fracture edema and tumor infiltration of the vertebral body. AJR Am J Roentgenol 2001;176:351–58 doi:10.2214/ajr.176.2.1760351 pmid:11159073

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Durando M,
    3. Gennaro L,
    4. Cho GY, et al

    . Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer. Eur J Radiol 2016;85:1651–58 doi:10.1016/j.ejrad.2016.06.019 pmid:27501902

    CrossRefPubMed
27. 27.↵
    2. Dwivedi DK,
    3. Kumar R,
    4. Bora GS, et al

    . Multiparametric MR can identify high grade prostatic intraepithelial neoplasia (HGPIN) lesions and predict future detection of prostate cancer in men with a negative initial prostate biopsy. Magn Reson Imaging 2016;34:1081–86 doi:10.1016/j.mri.2016.05.006 pmid:27211254

    CrossRefPubMed
28. 28.↵
    2. Traboulsee A,
    3. Simon JH,
    4. Stone L, et al

    . Revised recommendations of the Consortium of MS Centers Task Force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol 2016;37:394–401 doi:10.3174/ajnr.A4539 pmid:26564433

    Abstract/FREE Full Text
29. 29.↵
    2. Yanagihara TK,
    3. Grinband J,
    4. Rowley J, et al

    . A simple automated method for detecting recurrence in high-grade glioma. AJNR Am J Neuroradiol 2016;37:2019–25 doi:10.3174/ajnr.A4873 pmid:27418469

    Abstract/FREE Full Text
30. 30.↵
    2. Padhani AR,
    3. Liu G,
    4. Koh DM, et al

    . Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102–25 doi:10.1593/neo.81328 pmid:19186405

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Palle L,
    3. Reddy MB,
    4. Reddy KJ

    . Role of magnetic resonance diffusion imaging and apparent diffusion coefficient values in the evaluation of spinal tuberculosis in Indian patients. Indian J Radiol Imaging 2010;20:279–83 doi:10.4103/0971-3026.73544 pmid:21423903

    CrossRefPubMed
32. 32.↵
    2. Balliu E,
    3. Vilanova JC,
    4. Peláez I, et al

    . Diagnostic value of apparent diffusion coefficients to differentiate benign from malignant vertebral bone marrow lesions. Eur J Radiol 2009;69:560–66 doi:10.1016/j.ejrad.2007.11.037 pmid:18276098

    CrossRefPubMed
33. 33.↵
    2. Dewan KA,
    3. Salama AA,
    4. El habashy HM, et al

    . Evaluation of benign and malignant vertebral lesions with diffusion weighted magnetic resonance imaging and apparent diffusion coefficient measurements. The Egyptian Journal of Radiology and Nuclear Medicine 2015;46:423–33 doi:10.1016/j.ejrnm.2015.01.002

    CrossRef
34. 34.↵
    2. Ishijima H,
    3. Ishizaka H,
    4. Horikoshi H, et al

    . Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex. AJR Am J Roentgenol 1996;167:355–58 doi:10.2214/ajr.167.2.8686603 pmid:8686603

    CrossRefPubMed